| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 411 | 217 | 37 |
| Full Text Views | 3 | 1 | 0 |
| PDF Downloads | 2 | 2 | 0 |
Treatment of Urinary Bilharziasis in a Small Focus with Sodium Antimony Dimercaptosuccinate (Astiban®)
F. Arfaa
F. Arfaa
Institute of Public Health Research, Teheran University, Teheran, Iran
Search for other papers by F. Arfaa in
Current site
Google Scholar
PubMed
Search for other papers by F. Arfaa in
Current site
Google Scholar
PubMed
E. Tohidi
E. Tohidi
Institute of Public Health Research, Teheran University, Teheran, Iran
Search for other papers by E. Tohidi in
Current site
Google Scholar
PubMed
Search for other papers by E. Tohidi in
Current site
Google Scholar
PubMed
A. Ardelan
A. Ardelan
Institute of Public Health Research, Teheran University, Teheran, Iran
Search for other papers by A. Ardelan in
Current site
Google Scholar
PubMed
Search for other papers by A. Ardelan in
Current site
Google Scholar
PubMed
Summary
A slow method of administering sodium antimony dimercaptosuccinate was tried in 163 cases of haematobium bilharziasis in an effort to reduce side-effects. The drug was given over a period of 2½ weeks, the total amount being the same as tried previously in a short 5-day administration schedule.
The severity and number of side-effects were the same in both trials. However, the data suggest that the parasitologic rate of cure is reduced from 100% in the short schedule to 80% in the slow one.
Author Notes
Associate Professor, Institute of Public Health Research.
Epidemiologist, Institute of Public Health Research.
Senior Field Technician, Institute of Public Health Research.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 411 | 217 | 37 |
| Full Text Views | 3 | 1 | 0 |
| PDF Downloads | 2 | 2 | 0 |